Clinical Trial

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Name: Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy — clinical trial record (NCT07131956)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-17.

Trial Details

NCT Number	NCT07131956
Lead Sponsor	University of Erlangen-Nürnberg Medical School Collaborators: Bavarian Cancer Research Center (BZKF), University Hospital Augsburg, Ludwig-Maximilians - University of Munich
Conditions	Prostate Cancer (Diagnosis), Prostate Cancer Patients Who Have Brachytherapy Seed Implant, Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer Recurrent
Enrollment	200 participants
Start Date	2025-12
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-18